Logo for Climate Social Science Network (CSSN)


Andreas Vilhelmsson

Lund University Division of Occupational and Environmental Medicine

Based in


Andreas Vilhelmsson holds a Ph.D. in public health and works as a researcher and public health consultant with a broad interest in different aspects of human health, with a special focus on issues concerning global health, environmental health, climate change, mental health, pharmaceuticals (regulation, toxicology, and pharmacovigilance), pandemics, nudging, AI and digitalization.

Currently, he is working as a research assistant in a research project at the Division of Occupational and Environmental Medicine, Lund University looking at different environmental exposures and risk of cerebral pares. He is also involved in a project looking at how nudging techniques can be used within a clinical setting to change behavior.

Most importantly, he is currently working on a book on climate change and health that can be used within different courses in medicine, public health, sociology, and public policy. He also edits and writes for a Swedish climate and environmental blog.


Country(ies) of Specialty


Focus areas of expertise

Climate policy and politics Geoengineering Scientific assessments Behavioral action

How to Connect



Olofsson T, Vilhelmsson A, Hedlund M, Knaggård Å, Mulinari S. (2021). Comparative Covid Response: Crisis, Knowledge, Politics. Jasanoff S, Hilgartner S, Hurlbut, JB, Özgöde O, Rayzberg M. (eds.). 4 p

Mulinari S, Vilhelmsson A, Rickard E, Ozieranski P. (2020). “Five years of pharmaceutical industry funding of patient organisations in Sweden: cross sectional study of companies, patient organisations and drugs,” PLOS ONE; 15(6), June 24, 2020.

Vilhelmsson A, Mulinari M. (2020). “Pharmaceutical lobbying and pandemic stockpiling: A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand COVID-19.” Acta Sociologica; 63(4), October 8, 2020.

Vilhelmsson A, Mulinari S*. (2018). “Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics, Journal of Public Health; 40(3): 646–651, September 1, 2018.

Vilhelmsson A, Davis C, Mulinari S*. (2016). “Pharmaceutical industry off-label promotion and self-regulation: a document analysis of off-label promotion rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.” PLoS Medicine; 13(1), January 26, 2016.